Clinical value of geriatric nutritional risk index and pan-immune-inflammation value in locally advanced gastric cancer receiving neoadjuvant chemotherapy
Observational analysis finds that biomarkers improve outcomes in locally advanced gastric cancer patients, suggesting personalized treatment approaches.
Key Points
The GNRI and PIV scores are predictive biomarkers that can determine outcomes in patients undergoing neoadjuvant chemotherapy for locally advanced gastric cancer.
Patients receiving nutritional supplements show improved status, indicating a strong connection between nutrition and treatment effectiveness in this cancer population.
Assessment of geriatric nutritional risk index and pan-immune-inflammation value can enhance personalized care for gastric cancer patients during treatment.
Results suggest that integrating these scoring systems may lead to better patient management and outcomes in clinical settings.